---
$id: https://graph.org.ai/products/commodity/51142530
$type: Product
source: UNSPSC
code: "51142530"
title: "Lisuride"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lisuride

**UNSPSC Code**: 51142530
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C20H26N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E0QN3D755O, chemically known as 3-(9,10-didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea but generally known as lisuride, which bears US NIH Compound Identifier 28864. European Medicines Agency schedules Lisuride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08535MIG. The term LISURIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules lisuride in its Anatomical Therapeutic Chemical (ATC) Classification. LISURIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lisuride under HS 29396900 and SITC 54146. As of Q4 2014, LISURIDE remains the US FDA Preferred Term for this commodity. Lisuride bears US NLM identifiers UMLS ID C0023863 and NCI Concept Code C82247. SMILES: O=C(NC1CN(C2C(=C1)C1C3C(C2)C[NH]C3CCC1)C)N(CC)CC.

